Can ANCA (Antineutrophil Cytoplasmic Antibody)-associated vasculitis present with negative C-reactive protein (CRP) and low erythrocyte sedimentation rate (ESR)?

Can ANCA-Associated Vasculitis Present with Normal Inflammatory Markers?

Yes, ANCA-associated vasculitis can absolutely present with negative CRP and low ESR, and approximately 10% of AAV patients are persistently ANCA-negative as well. 1 The absence of elevated inflammatory markers should never exclude AAV from your differential diagnosis when clinical features are suggestive.

Key Diagnostic Principles

Biomarkers like CRP and ESR must be interpreted in the context of clinical findings, not used as standalone diagnostic criteria. 1 The 2024 KDIGO guidelines explicitly state that about 90% of patients with small-vessel vasculitis have ANCA positivity, meaning 10% do not—and these ANCA-negative patients are treated identically to ANCA-positive patients. 1

When to Suspect AAV Despite Normal Inflammatory Markers

Look for these specific clinical features that suggest active vasculitis regardless of CRP/ESR levels: 1

• Renal manifestations: Microscopic hematuria with dysmorphic red blood cells, red cell casts, moderate proteinuria (1-3 g/day), rapidly declining GFR over days to weeks
• Pulmonary-renal syndrome: Simultaneous lung and kidney injury, alveolar hemorrhage (affects 10% of AAV patients and increases mortality risk)
• Upper/lower respiratory tract involvement: Sinusitis, nasal crusting, pulmonary nodules or infiltrates
• Skin manifestations: Palpable purpura, infiltrated erythema indicating dermal small-vessel vasculitis 2
• Neurologic involvement: Mononeuritis multiplex, peripheral neuropathy
• Ocular involvement: Scleritis, episcleritis

Clinical Significance of Discordant Inflammatory Markers

The pattern of low ESR with high CRP actually carries prognostic significance. A 2022 study of 254 AAV patients found that those with low ESR/high CRP at diagnosis had significantly higher disease activity scores (BVAS) and worse all-cause mortality during follow-up compared to other patterns. 3 This discordance was associated with more frequent cardiovascular and nervous system manifestations. 3

Conversely, some patients present with low or normal levels of both markers despite active disease, particularly when:

• Disease is caught early with normal GFR 1
• Extrarenal manifestations predominate
• Slowly progressive course rather than rapidly progressive GN 1

Diagnostic Approach When Inflammatory Markers Are Normal

Do not wait for elevated CRP/ESR to pursue AAV diagnosis. Follow this algorithm:

1. Order ANCA testing immediately using antigen-specific immunoassays (ELISA) for both MPO-ANCA and PR3-ANCA 4

   • PR3-ANCA has 99% specificity and 73% sensitivity for GPA 4
   • MPO-ANCA is more common in MPA 4

2. Obtain urinalysis with microscopy looking for dysmorphic RBCs, RBC casts, and quantify proteinuria 1

3. Assess renal function using GFR estimating equations (MDRD or Cockcroft-Gault) 1

4. Consider tissue biopsy (kidney, lung, skin, or other affected organ) for definitive diagnosis 1

   • Kidney biopsy has 91.5% diagnostic yield in GPA 1
   • Shows pauci-immune necrotizing crescentic glomerulonephritis

Critical Treatment Decision Point

If clinical presentation is compatible with small-vessel vasculitis AND MPO- or PR3-ANCA is positive, start immunosuppressive therapy immediately without waiting for biopsy results, especially in rapidly deteriorating patients. 1 This applies even when CRP and ESR are normal.

The combination of:

• Compatible clinical picture
• Positive ANCA serology
• Low suspicion for secondary vasculitis

...is sufficient to begin treatment with glucocorticoids plus rituximab or cyclophosphamide. 1

Monitoring Limitations

Sequential CRP and ESR monitoring is less reliable than ANCA monitoring for predicting relapse. A 1995 study found that rises in CRP occurred in only 38% of relapses and ESR in 33%, while ANCA rises preceded 57% of relapses by a mean of 7.8 weeks. 5 However, clinical relapse can occur with negative ANCA in some patients. 5

Common Pitfall to Avoid

Never dismiss AAV based solely on normal inflammatory markers. The diagnosis relies on the constellation of clinical findings, imaging, laboratory tests (including complete blood count, kidney parameters, urine sediment), and ANCA serology—not just CRP and ESR. 1 Waiting for inflammatory markers to rise before pursuing diagnosis or treatment can result in irreversible organ damage, particularly rapidly progressive glomerulonephritis leading to end-stage renal disease.